Medcxy

Product dossierBuilt from registrations, label text and platform-curated data

Revanesse ReviseRevanesse Revise 1.0 mL

Ask about this product

Revanesse Revise is a Hyaluronic acid filler product (Class III device), registered by Prollenium Medical Technologies Inc.. Linked registrations: EU B-PN40097QL, EU B-PN40098QN, EU B-PN40114PT and 5 more. Data as of 2026-11-09.

  • Regulatory classHyaluronic acid filler · Class III device
  • HolderProllenium Medical Technologies Inc.
  • JurisdictionsEU · UK
  • Updated2026-11-09 · v1

Registration and basics are public; findings and prices need an account

Registration and basics

Revanesse Revise

Product
Regulatory class
Class III device
Category
Hyaluronic acid filler
EU · EUDAMED device record
B-PN40097QL
EU · EUDAMED device record
B-PN40098QN
EU · EUDAMED device record
B-PN40114PT
EU · EUDAMED device record
B-PN40139QB
UK · MHRA device registration (not an approval)
PARD-3315763
UK · MHRA device registration (not an approval)
PARD-3283627
UK · MHRA device registration (not an approval)
PARD-2146006
UK · MHRA device registration (not an approval)
PARD-2146014
Other registrations
1 more, see the timeline
Name on registration
Revanesse® Revise 1.0 mL
Registrant
Prollenium Medical Technologies Inc.
EU authorised representative
Emergo Europe B.V.（NL-AR-000000116）
First approval
Not obtained from an official source
Checked against official page
Not yet checked field by field against the live official page

Public: fields from the registration record.Registrant and dates are from B-PN40097QL; 9 registrations linked.

Label facts by jurisdiction

What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A

No data yet

Registration timeline

  1. UK

    PARD-2146006 registered

  2. UK

    PARD-2146014 registered

  3. UK

    PARD-2146031 registered

  4. UK

    PARD-3283627 registered

  5. UK

    PARD-3315763 registered

First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record. Dates on non-Chinese registrations keep the source's wording: UK devices show the registration date (MHRA does not approve them), Australia the ARTG start date, FDA devices the decision date.

Cross findings · Price observations

Sign in to see findings and prices

Findings and prices stay out of indexable pages.

Sign in to view

Recent changes

5
  • PARD-3315763: registered2022-07-19
  • PARD-3283627: registered2022-07-01
  • PARD-2146006: registered2021-12-02
  • PARD-2146014: registered2021-12-02
  • PARD-2146031: registered2021-12-02

Sources

9